AZN INVESTOR NOTICE: Robbins Geller Rudman and Dowd LLP are informing AstraZeneca PLC investors who have suffered substantial losses that they may have the chance to lead a class action lawsuit.
Robbins Geller Rudman & Dowd LLP has stated that individuals who bought or acquired AstraZeneca PLC (NASDAQ: AZN) publicly traded securities during the period from February 23, 2022 to December 17, 2024…